Derion Blackman, a heart transplant recipient, died in March after a two-month delay in accessing vital antirejection medications following a switch to a cheaper health plan. His wife, Sonja Smith, said the couple switched from their Federal Employees Health Benefits plan to CHAMPVA—a program for dependents of disabled veterans—after their premiums more than doubled to $307 and their deductible increased. Despite careful planning, Blackman faced repeated hurdles getting approval for his medications under the new plan, which had no premium but a $3,000 deductible. He ran out of his life-saving drugs before approvals were finalized.
Smith blamed CHAMPVA, the Trump administration, and the broader healthcare system for her husband's death. The Department of Veterans Affairs declined to comment on the case. The couple's experience underscores the difficulties many Americans face when seeking affordable healthcare options amid rising insurance costs.
Background on the Health Plans
The Federal Employees Health Benefits plan is a federal government program offering health insurance to civilian employees and retirees. CHAMPVA, administered by the Department of Veterans Affairs, provides coverage to eligible dependents of veterans with service-connected disabilities. While CHAMPVA has no premium, it requires a higher deductible and may have stricter approval processes for certain medications.
Wider Implications
The U.S. healthcare system is fragmented, with insurers, government programs, and private plans often operating under different rules. Rising costs have forced many Americans to switch plans, sometimes leading to gaps in coverage. Advocates argue for reforms to streamline transitions between plans, particularly for patients with chronic or life-threatening conditions.